// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Ex Situ Heart Perfusion Improves Preservation of Endothelial Function in Both DBD and DCD Hearts

R. Ribeiro - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac arrest

N/A

Assessment of Predictive Biomarkers Associated with Ischemia/Reperfusion Injury and Primary Graft Dysfunction in Lung Transplants

C. Landry - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Other

Ischemia-reperfusion injury

N/A

Contractility versus Metabolic Cardiac Assessment during Ex Situ Heart Perfusion: A Pre-Clinical Transplant Study

R. Ribeiro - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac arrest

N/A

Ees Estimation Using Machine Learning Approach during Ex Vivo Heart Perfusion to Predict Early Graft Survival: A Preliminary Study in Porcine Model

L. Xin - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Comparative Behaviour of Allogeneic Spleen versus Bone Marrow Cells in Non-Conditioned Neonatal Mice: Insights into Robust Heart Transplant Tolerance

R.A. Bascom - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Graft-versus-host disease

N/A

Decreased Club Cell Secretory Protein in Bronchoalveolar Lavage is Associated with Chronic Lung Allograft Dysfunction (CLAD) but Not with CLAD Phenotypes

L. Levy - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Transplant rejection

Uteroglobin

CRISPR-Mediated IL-10 Gene Activation as a Novel Gene Therapeutic Strategy in Lung Transplantation

K. Mesaki - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Interleukin-10

Lung Bile Acid as Biomarker of Microaspiration and Its Relationship to Lung Inflammation

M. Ahmed - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Gastroesophageal reflux disease

intrarectal sodium taurocholate

Lung T Cell Activation in an Outbred Pig Transplant and Ischemia-Reperfusion Injury Model

A. Duong - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Ischemia-reperfusion injury

N/A

Behavioural Economic Nudge Policy, Organ-Donation and Heart Transplant Conversion Rates in Alberta, Canada. A Ten-Year Retrospective Analysis

P.F. Kantor - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Application of Predicted Heart Mass Difference in a Canadian Cohort of Heart Transplant Recipients

V.M. Molinero - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Other

Primary graft dysfunction

N/A

Heart Transplant Induction Therapy in Canada: A National Survey

S. Jia - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Heart Transplant Patients with Histologic Normal and Molecular Microscope Abnormal Biopsies: An Exploratory Analysis

K. Shah - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Chronic antibody mediated rejection

N/A

Drug Resistant CMV Infection in Lung Transplantation Patients: Incidence, Characteristics and Clinical Outcomes

E. Helivaara - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Cytomegalovirus infection

N/A

Antifungal Prophylaxis in Lung Transplant Recipients: A Network Meta-Analysis

S. Herrera - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Factors That Predict the Successful Utilization of Donor Lungs after Ex-Vivo Lung Perfusion

P.H. Lematre - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Predictors of Mortality Post Lung Transplantation: Systematic Review and Meta-Analysis

F. Foroutan - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Effect of PEEP-Induced Alveolar Recruitment on Lung Injury during Extracorporeal Membrane Oxygenation for ARDS

B.M. Gomes - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Acute lung injury

N/A

Longer Duration of Donor Ventilation Does Not Impact Long-Term Lung Function after Lung Transplantation

A. Hirji - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Other

Primary graft dysfunction

N/A

Right Ventricular Failure Risk Prediction Models in Patients Undergoing Left Ventricular Assist Device Implantation: A Systematic Review

C. Frankfurter - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Right ventricular failure

N/A

Copyright © 2026. QuantiNova All rights reserved